Medical Assistive Robotics · MAR1
Human insight.
Robotic consistency.
MAR1 is an AI-assisted automated CPR platform in development, designed to deliver consistent chest compressions while supporting clinical teams through the wider resuscitation workflow. It is a prototype — not available for clinical use or sale.
MAR1 · Simulated interface concept
NON-CLINICAL
- Rate
- 110cpm
- Depth
- 51mm
- Mode
- Mimicinput
- Oversight
- Clinicianin loop
The challenge
Manual compressions are demanding to sustain.
During prolonged resuscitation, compression rate, depth and recoil can vary as responders fatigue, as teams rotate, and as attention is divided across airway, rhythm analysis, drugs and communication. Guidelines are clear; sustaining them under pressure is hard.
Our approach
Consistency the team can rely on
MAR1 is being developed to support consistent rate, depth and force under clinician direction, freeing responders to concentrate on the wider resuscitation workflow. Sensor feedback is designed to make delivery visible, so the team can adjust or intervene immediately.
We make no claims about patient outcomes. MAR1 has not been evaluated clinically, and any performance or clinical benefit must be established through formal verification, validation and appropriately designed studies with clinical partners.
MAR1 technology
Five capabilities defining the MAR1 prototype.
Each capability below describes design intent for the current engineering prototype. Specifications remain under development and are subject to change through verification.
Automated compression control
A closed-loop actuation concept intended to hold a set compression rate, depth and force profile steadily throughout a resuscitation attempt.
Clinician-guided Mimic Mode
Captures a short clinician-led compression pattern and uses it as an input to the control system, so automated delivery reflects trained human technique.
Multi-sensor feedback
Position, force and motion sensing are being developed to inform the controller in real time and to flag deviations from the selected protocol.
Rapid deployment target
Design work targets fast, low-friction placement so automated support can follow manual compressions with minimal interruption.
Safety-first architecture
Emergency stop, mechanical and software limits, continuous monitoring and immediate manual override are core architectural requirements, not add-ons.
Intended prototype workflow
How MAR1 is intended to work.
The sequence below describes the intended workflow for the prototype under clinician direction. It is a design description, not an instruction for use, and does not reflect a cleared or validated product.
- 01
Position & secure
The device is placed and secured over the patient's chest in line with the team's resuscitation protocol.
- 02
Set protocol
The clinician selects compression parameters, or records a short pattern using Mimic Mode as a control input.
- 03
Confirm & start
Settings are confirmed on the interface before automated compressions begin, with manual override always available.
- 04
Monitor & adapt
Sensor feedback is displayed so the team can monitor delivery, adjust parameters or stop the device instantly.
Development status
An honest, staged development pathway.
We publish stage status rather than dates. No regulatory approval, clearance or certification has been obtained, and none is implied by the stages below.
- Stage 1Complete
Concept & architecture
Core clinical concept, system architecture and safety principles defined, including the Mimic Mode control approach.
- Stage 2In progress
Engineering prototype
Mechanical, electronic and software subsystems are being built and iterated on the bench to validate the control concept.
- Stage 3Planned
Verification & validation planning
Test strategy, requirements traceability and bench protocols are being prepared ahead of formal verification activity.
- Stage 4Planned
Regulatory pathway & clinical collaboration
Regulatory strategy work and engagement with prospective clinical research partners to shape evaluation studies.
- Stage 5Planned
Manufacturing readiness
Design for manufacture, quality processes and supply strategy to prepare for controlled production volumes.
Clinical & engineering principles
The commitments shaping every design decision.
Clinician oversight
The clinical team remains in control. Automation supports decisions; it never replaces them.
Repeatability
Consistent, measurable mechanical delivery is the central engineering objective.
Traceability
Requirements, design decisions and test evidence are linked throughout development.
Fail-safe design
Foreseeable faults should lead to a safe state with rapid handover to manual compressions.
Human factors
Interfaces are designed for high-stress, time-critical use with minimal cognitive load.
Data protection
Data handling is designed with privacy, minimisation and security in mind from the outset.
Partnership
Three ways to build MAR1 with us.
MAR1's progress depends on clinical insight, engineering depth and patient capital. If your organisation works in any of these areas, we would welcome a conversation.
Clinical research partners
Hospitals, resuscitation leads and academic groups interested in shaping evaluation design, simulation studies and human factors research.
Discuss clinical collaborationEngineering & manufacturing partners
Specialists in precision mechanics, actuation, embedded electronics, medical-grade assembly and quality systems.
Explore an engineering partnershipInvestment & strategic partners
Healthcare investors and strategic partners supporting development through prototype maturity towards regulated evaluation.
Start an investor conversationCompany
Building the next generation of medical-assistive robotics.
Medical Assistive Robotics Company Ltd develops intelligent assistive systems for emergency and critical care. Our work is deliberately multidisciplinary: medicine and resuscitation practice, mechanical and electrical engineering, software and AI, human factors, quality management and regulatory strategy contribute to every design decision.
How we work
- Clinically grounded. Design intent is informed by resuscitation practice and clinician-led review.
- Evidence before claims. We describe design intent and development stage, and reserve performance claims for verified results.
- Safety as architecture. Override, limits and monitoring are foundational requirements of the system.
- Collaborative by design. We build with clinical, engineering and manufacturing partners rather than in isolation.
Contact
Start a conversation with MAR.
Tell us who you are and how you would like to work with us. Enquiries about investment, clinical research and engineering partnerships are all welcome.